For more information, or to subscribe, contact:
April 2025. Reviews plans' priorities in specialty drug cost containment for 2025 and examines activities in utilization management, medical benefit management, formulary and benefit design, and specialty pharmacy network optimization. Reviews the status of biosimilars uptake. Provides market access dashboards and management trends across 14 specialty therapeutic areas.
March 2025. Reviews health plan nominations of overall specialty manufacturer "Partner of Choice" and most valuable manufacturer-sponsored program/resource offerings for specialty. Benchmarks 35+ manufacturers in account support and willingness to contract for their specialty portfolios. Examines the evolving contracting environment across several specialty therapeutic classes and evaluates opportunities for partnership.
September 2024. Reviews MA plans' strategies to manage drug costs and utilization across several high profile specialty therapeutic classes, examines the contracting environment, and provides MA plan decision-makers evaluation of best-in-class manufacturer engagement.
June 2024. Provides an overview of specialty pharmaceutical spending and trends in distribution of specialty drugs. Examines recent notable SPP market activity and trends, and SPPs' most pressing strategic imperatives. Examines SPP service offerings for health plans and manufacturers. Provides profiles for the top industry-leading specialty pharmacy providers.
May 2024. Examines SPPs' manufacturer "Partner of Choice," manufacturer collaboration initiatives with SPPs, best-in-class account manager nominations, and and benchmark ratings of manufacturers in account support and willingness to contract. Examines the contracting environment across 12 specialty therapeutic classes.
April 2024. Examines PBMs involvement in specialty drug distribution, specialty medication management and formulary tactics, and trends in contracting with manufacturers.
Payers remain focused on optimizing strategies to manage specialty drug cost and utilization as the drug spend continues to rise. HIRC's Specialty Pharmaceuticals Service assists pharmaceutical manufacturers in developing and maintaining successful market access strategies by monitoring trends in payers' specialty medication management initiatives, issues in channel distribution, and manufacturer engagement with key customers. HIRC utilizes a triangulated research design, combining primary survey data, interview insights, and in-depth secondary research, resulting in a deep understanding of issues related to specialty pharmaceutical market access.
*Select Market Segments
For more information or to subscribe, contact Danielle Snook via email or at (408) 884-8560
The service monitors specialty drug management and manufacturer benchmarking and contracting trends across both Commerical and Medicare Advantage plan market segments. It also tracks trends and manufacturer engagement within the specialty pharmacy provider distribution channel.
HIRC's data and insights enable subscribers to understand and track market dynamics and trends critical to optimal product and value-added program positioning as the specialty market evolves. Through detailed analyses, key implications, and strategic recommendations from experienced HIRC researchers, subscribers to the Specialty Pharmaceuticals Service are able to understand the specialty market landscape, evaluate account support, identify specialty-specific managed care needs, and act upon partnership opportunities.
